| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 23,430 | $30 | $796.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 50,850 | $10 | $508.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 61,200 | $1 | $244.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,820 | $30 | $203.3K |
| J3262 | Injection, tocilizumab, 1 mg | 37,880 | $10 | $189.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 580 | $100 | $55.6K |
| J0897 | Injection, denosumab, 1 mg | 2,940 | $20 | $52.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $90 | $40.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 230 | $50 | $12.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 240 | $50 | $11.1K |